{
  "retracted": false,
  "timestamp": 1469059200000,
  "updates": [
    {
      "timestamp": 1585201981067,
      "identifier": {
        "doi": "10.1182/blood-2016-06-721886"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1182/blood-2015-11-682518"
  },
  "publisher": "American Society of Hematology",
  "title": "Baz RC, Martin TG III, Lin H-Y, et al. Randomized multicenter phase 2 study of pomalidomide, cyclophosphamide, and dexamethasone in relapsed refractory myeloma. Blood. 2016;127(21):2561-2568."
}
